Internal Medicine, Hepatology · Newark, NJ
NPI
1528087509
Since 2006
Specialty
Internal Medicine, Hepatology
Code 207RI0008X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
140 Bergen St # D-1650
Newark, NJ, 07103
Phone (973) 972-9000
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
494 services
Medicare patients, 2024
172
Average age 68
Drug cost, 2024
$1.5M
3,259 prescriptions
Company payments, 2025
$110
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mumtaz A Niazi was code 99214 (office e&m - established), 148 times for 109 patients. In total Mumtaz A Niazi billed 494 services in 12 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 148 | 109 | $74.89 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 141 | 46 | $66.77 | $9,414 |
| 99233 Hospital E&M - Subsequent | Facility | 89 | 16 | $100.17 | $8,915 |
| 99223 Hospital E&M - Initial | Facility | 48 | 39 | $143.38 | $6,882 |
| 99239 Hospital Discharge Management | Facility | 25 | 17 | $97.64 | $2,441 |
| 99213 Office E&M - Established | Facility | 15 | 12 | $52.40 | $786 |
By year: 2022 $35K for 437 services; 2023 $47K for 539 services; 2024 $42K for 494 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mumtaz A Niazi prescribed most often to Medicare patients was Tacrolimus, with 368 prescriptions and refills. In total Mumtaz A Niazi wrote 3,259 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 368 | 589 | 91 | $34K |
| Xifaxan Rifaximin | 264 | 264 | 49 | $855K |
| Furosemide Generic | 246 | 370 | 72 | $861 |
| Spironolactone Generic | 235 | 351 | 67 | $2,894 |
| Carvedilol Generic | 231 | 325 | 67 | $1,088 |
| Lactulose Generic | 166 | 184 | 41 | $5,008 |
| Mycophenolate Mofetil Generic | 158 | 237 | 36 | $11K |
| Ursodiol Generic | 142 | 207 | 33 | $14K |
| Pantoprazole Sodium Generic | 121 | 162 | 39 | $924 |
| Midodrine Hcl Generic | 109 | 130 | 27 | $8,554 |
| Vemlidy Tenofovir Alafenamide | 109 | 123 | 19 | $166K |
| Mycophenolic Acid Mycophenolate Sodium | 109 | 141 | 28 | $22K |
| Amlodipine Besylate Generic | 84 | 134 | 24 | $474 |
| Entecavir Generic | 72 | 126 | 18 | $19K |
| Tenofovir Disoproxil Fumarate Generic | 67 | 114 | 15 | $14K |
Brand drugs: - claims; generic drugs: 2,774 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mumtaz A Niazi $110 ($110 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $110.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 1 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.